Mixed Hearing Loss
16
1
1
14
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
6%
1 trials in Phase 3/4
50%
7 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (16)
Evaluation of Actual Maximum Gain in Bone Anchored Devices
Evaluation of a Hearing Device for Transmitting Sound to the Inner Ear
Evaluation of Sound Processor for a Transcutaneous System
Osia 2 Pediatric Expansion Study
Ambispective Clinical Evaluation of Sophono™
Long Term Results With the Vibrant Soundbridge in Patients With Mixed Hearing Loss: a 60-month Longitudinal Study
Objective Measures in Implantable Hearing Devices
Evaluation of the Effectiveness of Bone-anchored Hearing Aids (Baha)
Osia CPT Code Study
Clinical Study of Minimally Invasive Ponto Surgical Technique (MIPS) - Design Iteration
Subject´s Preference Regarding Hearing Performance and Functionality Using a New Sound Processor
Clinical Performance of a New Implant System for Bone Conduction Hearing
Clinical Survey of Minimally Invasive Ponto Surgical Technique (MIPS)
Clinical Survey of Oticon Medical Ponto Implants and a Surgical Technique With Tissue Preservation
Clinical Survey of Different Abutment Topologies
Clinical Survey of Oticon Medical Healing Cap